Published in Viral Immunol on February 01, 2009
The global ecology and epidemiology of West Nile virus. Biomed Res Int (2015) 1.21
Vector competence of Culex neavei and Culex quinquefasciatus (Diptera: Culicidae) from Senegal for lineages 1, 2, Koutango and a putative new lineage of West Nile virus. Am J Trop Med Hyg (2014) 0.91
First serological evidence of West Nile virus in human rural populations of Gabon. Virol J (2010) 0.77
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet (2004) 3.01
Relative safety of first-time volunteer and replacement donors in West Africa. Transfusion (2009) 2.50
Humanitarian ventures or 'fistula tourism?': the ethical perils of pelvic surgery in the developing world. Int Urogynecol J Pelvic Floor Dysfunct (2006) 2.14
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Transfusion-transmitted hepatitis B virus infection. J Hepatol (2009) 1.70
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood (2002) 1.66
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol (2004) 1.37
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods (2004) 1.33
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol (2008) 1.25
Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol (2007) 1.23
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol (2007) 1.06
A pool of repeat blood donors can be generated with little expense to the blood center in sub-Saharan Africa. Transfusion (2008) 1.04
Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology (2006) 1.04
Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol (2005) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J Med Virol (2004) 1.00
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion (2009) 1.00
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population. J Med Virol (2007) 1.00
Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol (2011) 1.00
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
Increasing threat of brucellosis to low-risk persons in urban settings, China. Emerg Infect Dis (2014) 0.98
A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol (2009) 0.98
External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med (2012) 0.98
DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice. J Biol Chem (2012) 0.97
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol (2008) 0.96
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis (2011) 0.95
Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Mol Cancer Ther (2009) 0.95
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94
Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J (2015) 0.94
Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals (2010) 0.93
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol (2009) 0.93
Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol (2013) 0.92
The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion (2009) 0.92
Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011. Arch Virol (2014) 0.92
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol (2008) 0.89
Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion (2012) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine. Clin Vaccine Immunol (2007) 0.89
Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol (2009) 0.87
Nucleic acid dipstick test for molecular diagnosis of pandemic H1N1. J Clin Microbiol (2010) 0.87
Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors. Transfusion (2014) 0.86
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev (2014) 0.86
Deferred donor care in a regional hospital blood center in Ghana. Transfusion (2008) 0.86
Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS (2004) 0.86
Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo. PLoS One (2012) 0.86
Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol (2006) 0.85
Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion (2006) 0.85
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev (2012) 0.84
Infection of common marmosets with hepatitis C virus/GB virus-B chimeras. Hepatology (2014) 0.84
Can family or replacement blood donors become regular volunteer donors? Transfusion (2013) 0.84
Six-year pilot study on nucleic acid testing for blood donations in China. Transfus Apher Sci (2013) 0.83